Imaging of High Grade Prostate Cancer
- Conditions
- Prostatic Carcinoma
- Interventions
- Device: Imaging
- Registration Number
- NCT02177526
- Lead Sponsor
- Ottawa Hospital Research Institute
- Brief Summary
Management of prostatic carcinoma varies according to stage of disease. Trans-rectal ultrasound guided biopsy is known to underestimate the degree of tumor due to undersampling and random non-targeted technique. Methods to improve pre-operative tumor localization and grading, including multi-parametric (MP) magnetic resonance imaging (MRI) is an active area of research but requires further validation.
High grade tumors can undergo comedo-type necrosis with malignant calcifications which only occurs in Gleason pattern 5 tumors and which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI.
Detection of malignant calcification within tumor foci will improve the accuracy of localization and grading in prostatic carcinoma.
- Detailed Description
High grade (Gleason pattern 5) tumors can undergo comedo-type necrosis producing malignant calcifications which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI. Detection of malignant calcifications in areas of Gleason pattern 5 tumor will improve the accuracy of pre-operative localization and grading in prostatic carcinoma.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Male
- Target Recruitment
- 30
- Patients with malignant comedo-type necrosis and calcifications detected with histo-pathology from guided biopsies
- Patients with biopsy proven Gleason pattern 5 tumor and without comedo-type necrosis associated calcification
- Patients who do not have malignant comedo-type necrosis and calcifications detected with histo-pathology from guided biopsies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Imaging - CT and MRI examinations Imaging Abdominal and pelvic CT and pelvic MRI imaging will be performed in 30 patients.
- Primary Outcome Measures
Name Time Method The number of prostate patients with comedo-type necrosis. up to 4 weeks Two radiologists will review the MRI and CT examinations separated by a 4 week interval to decrease recall bias. Further, readers will review the 3 additional gradient echo pulse sequences independently at 3 different MRI reading sessions, also separated by 4 weeks, in order to compare the accuracy from each pulse sequence and to reduce recall bias.
- Secondary Outcome Measures
Name Time Method The number of other features measured on MRI. up to 4 weeks Two radiologists will review the MRI and CT examinations separated by a 4 week interval to compare other MRI features and clinical factors between Gleason pattern 5 tumors with and without malignant calcification.
Trial Locations
- Locations (1)
Ottawa Hospital (Civic Campus)
🇨🇦Ottawa, Ontario, Canada